Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• TRAIL is a death receptor ligand with selective proapoptotic effects on cancer cells.
• TRAIL's therapeutic potential is linked to its ability to induce cancer cell death.

Purpose of the Study:

• To investigate chromatin alterations and DNA damage response (DDR) pathways activated by TRAIL.
• To elucidate the molecular mechanisms and signaling pathways downstream of TRAIL-induced apoptosis.

Main Methods:

• Immunofluorescence confocal microscopy to visualize protein localization and phosphorylation.
• Inhibition of caspases and inactivation of Bax to assess the role of the mitochondrial pathway.
• Gene silencing (downregulation of Chk2) to evaluate its impact on TRAIL-induced apoptosis.

Main Results:

• TRAIL rapidly activates DDR pathways, evidenced by histone H2AX, Chk2, ATM, and DNA-PK phosphorylations.
• TRAIL induces a distinct gamma-H2AX ring and peripheral nuclear staining of DDR proteins within heterochromatin.
• TRAIL-induced DDR is downstream of the mitochondrial pathway and dependent on caspases and Bax.
• Chk2 activation is crucial for TRAIL-induced cell detachment, caspase activation, and cancer cell killing, operating independently of p53.

Conclusions:

• TRAIL activates a novel DDR pathway involving nuclear Chk2, which forms a positive feedback loop with the mitochondrion-dependent caspase cascade.
• This TRAIL-induced DDR mechanism contributes significantly to cancer cell apoptosis, offering potential therapeutic insights.